We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.36B
AUM Growth
-$421M
Cap. Flow
-$494M
Cap. Flow %
-36.22%
Top 10 Hldgs %
24.41%
Holding
4,677
New
965
Increased
1,296
Reduced
1,507
Closed
833

Sector Composition

Rank Sector Weight
1 Industrials 7.55%
2 Technology 7.19%
3 Financials 6.96%
4 Healthcare 6.81%
5 Consumer Discretionary 5.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZIV
2926
DELISTED
VelocityShares Daily Inverse VIX Medium Term ETN
ZIV
$8K ﹤0.01%
+105
New +$8.19K
QHC
2927
DELISTED
Quorum Health Corporation
QHC
$8K ﹤0.01%
1,327
-12,073
-90% -$55.5K
QTRH
2928
DELISTED
Quarterhill Inc. Common Shares
QTRH
$8K ﹤0.01%
6,000
-3,373
-36% -$4.37K
DF
2929
DELISTED
Dean Foods Company
DF
$8K ﹤0.01%
1,073
-6,431
-86% -$56.2K
AMR
2930
DELISTED
Alta Mesa Resources Inc
AMR
$8K ﹤0.01%
1,988
+1,694
+576% +$9.29K
AMBR
2931
DELISTED
Amber Road Inc
AMBR
$8K ﹤0.01%
+837
New +$7.45K
FTD
2932
DELISTED
FTD Companies, Inc. Common Stock
FTD
$8K ﹤0.01%
3,008
-8,771
-74% -$32.2K
ZGNX
2933
DELISTED
Zogenix, Inc.
ZGNX
$8K ﹤0.01%
153
+133
+665% +$6.77K
ASCMA
2934
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$8K ﹤0.01%
4,728
+4,495
+1,929% +$11.6K
EBIX
2935
DELISTED
Ebix Inc
EBIX
$8K ﹤0.01%
+102
New +$8.12K
GFA
2936
DELISTED
Gafisa S.A.
GFA
$8K ﹤0.01%
1,489
+930
+166% +$5.38K
SAFE
2937
DELISTED
Safehold Inc.
SAFE
$8K ﹤0.01%
416
-5,109
-92% -$90.8K
AAL icon
2938
American Airlines Group
AAL
$9.93B
$7K ﹤0.01%
176
-24,702
-99% -$965K
ACRS icon
2939
Aclaris Therapeutics
ACRS
$867M
$7K ﹤0.01%
+464
New +$7.95K
ADAP
2940
DELISTED
Adaptimmune Therapeutics
ADAP
$7K ﹤0.01%
496
-1,465
-75% -$15.4K
AWF
2941
AllianceBernstein Global High Income Fund
AWF
$870M
$7K ﹤0.01%
582
-18
-3% -$209
CCNE icon
2942
CNB Financial Corp
CCNE
$1.02B
$7K ﹤0.01%
253
-2,387
-90% -$73.5K
CLIR icon
2943
ClearSign Technologies
CLIR
$26.5M
$7K ﹤0.01%
+449
New +$8.72K
COLL icon
2944
Collegium Pharmaceutical
COLL
$882M
$7K ﹤0.01%
447
-1,668
-79% -$29.6K
CRK icon
2945
Comstock Resources
CRK
$4.22B
$7K ﹤0.01%
+778
New +$7.29K
CYBR
2946
DELISTED
CyberArk
CYBR
$7K ﹤0.01%
90
+86
+2,150% +$6.04K
CZWI icon
2947
Citizens Community Bancorp
CZWI
$197M
$7K ﹤0.01%
483
+399
+475% +$5.62K
DAR icon
2948
Darling Ingredients
DAR
$9.99B
$7K ﹤0.01%
358
+283
+377% +$5.58K
EFAS icon
2949
Global X MSCI SuperDividend EAFE ETF
EFAS
$54M
$7K ﹤0.01%
416
+116
+39% +$2K
ESI icon
2950
Element Solutions
ESI
$9.08B
$7K ﹤0.01%
600
-5,492
-90% -$68.6K

Similar funds

Tower Research Capital (TRC)'s Q3 2018 Portfolio in Review

As of Q3 2018, Tower Research Capital (TRC) held 4,677 positions worth $1.36B, down 24% from $1.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Tower Research Capital (TRC) withdrew a net $494M in Q3 2018, closing 833 positions and reducing 1,507 holdings. Its most notable exit was NVIDIA, an estimated $6.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 7.5% of assets, up from 7.3% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.3M.

  • Tower Research Capital (TRC)'s largest Q3 2018 buy was Vanguard S&P 500 ETF: 53,562 shares worth $14.3M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $151M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2018 reduction was Apple, cutting an estimated $48.1M.
  • Tower Research Capital (TRC) fully exited NVIDIA in Q3 2018, selling an estimated $6.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 24% of its $1.36B portfolio in Q3 2018.
  • Tower Research Capital (TRC) opened 965 new positions and closed 833 in Q3 2018.
  • Tower Research Capital (TRC)'s portfolio value fell 24% quarter-over-quarter to $1.36B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2018, filed 13 Nov 2018.